2001
DOI: 10.1006/mgme.2000.3124
|View full text |Cite
|
Sign up to set email alerts
|

Dexamethasone Alters TNF-α Expression in Retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 20 publications
1
9
0
1
Order By: Relevance
“…It has been reported that the mRNA level of TNF-a is elevated in a mouse model of ischemia-induced retinal neovascularization [10,22]. In this study, we demonstrated that TNF-a is expressed in the macrophages/microglia in the same mouse model which suggested that the increased expression of TNF-a might be partly due to the enhanced expression of TNF-a by macrophages/microglia.…”
Section: Discussionsupporting
confidence: 42%
“…It has been reported that the mRNA level of TNF-a is elevated in a mouse model of ischemia-induced retinal neovascularization [10,22]. In this study, we demonstrated that TNF-a is expressed in the macrophages/microglia in the same mouse model which suggested that the increased expression of TNF-a might be partly due to the enhanced expression of TNF-a by macrophages/microglia.…”
Section: Discussionsupporting
confidence: 42%
“…First, steroids could reduce the expression of tumour necrosis factor alpha, which has an angiogenic and inflammatory role in the pathogenesis of proliferative retinopathy, and hence reducing ROP development 49. Second, steroids may reduce the oxidative stress 50.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies suggested that prenatal steroid exposure may decrease the risk of ROP, [25][26][27][28][29] possibly because of glucocorticoidmediated acceleration of retinal vascular maturation and inhibition of tumor necrosis factor-␣ production, a key factor in inflammatory and angiogenic mechanisms. 29 In our previous neonatal outcome study of this cohort, there were no statistical differences in the risks of ROP or severe ROP associated with either dexamethasone or betamethasone, compared with no prenatal steroid exposure or with each other. The current study had a very low rate of blindness, however, and the possibility of a type II error cannot be ruled out.…”
Section: Discussionmentioning
confidence: 99%